Attovia Therapeutics | $105,000,000 | (May 14, 2024)
Glacis Labs | $2,000,000 | (May 14, 2024)
hexafarms | $1,403,746 | (May 14, 2024)
Veho
United States
- San Francisco, California
- 15/02/2022
- Series B
- $170,000,000
Built for the age of e-commerce, Veho is an end-to-end delivery service that puts customer experience in the center. Our network of professional and qualified flexible drivers, powered by our proprietary technology, allows any brand to delight customers like never before. We help our customers cut their shipping costs, gain full visibility into all of their shipments, and build customer loyalty with an incredible shipping experience. Welcome to package delivery, reinvented.
We’re a team of builders, creatives, adventurers, and go-getters on a mission to revolutionize the world of package delivery by creating exceptional experiences for customers and drivers. Come join us!
Winner of the Harvard Business School New Venture Competition 2017. Backed by top industry leaders such as the former CEO of FedEx Supply Chain and executives at UPS and Amazon.
- Industry Consumer Services
- Website https://shipveho.com/
- LinkedIn https://www.linkedin.com/company/shipveho/about/
CereVasc | $70,000,000 | (May 14, 2024)
GigPig | $1,631,441 | (May 14, 2024)
Active Surfaces | $5,600,000 | (May 14, 2024)
May Health | $25,000,000 | (May 14, 2024)
ByHeart | $95,000,000 | (May 14, 2024)
tiney | $9,034,812 | (May 14, 2024)
Hexis | $2,009,680 | (May 14, 2024)
Nivoda | $30,000,000 | (May 14, 2024)
Switchboard Health | $6,500,000 | (May 14, 2024)